Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.
LizarBio Therapeutics has raised $525K in total funding. The most recent round was Seed. The last funding was announced in March 2022.
LizarBio Therapeutics's investors include SOSV, SOSV SF & NY (Fka IndieBio), Kria, Libbs Farmacêutica.
LizarBio Therapeutics is headquartered in Dover, United States.
Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.
LizarBio Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LizarBio Therapeutics — Funding & Investors." VCBacked, March 7, 2022, https://www.vcbacked.co/company/lizarbio-therapeutics. Accessed August 15, 2026.
VCBacked. (2022). LizarBio Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/lizarbio-therapeutics
{{cite web |title=LizarBio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lizarbio-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated